Skip to content

Serotonin: all studies

Page 366 of 400: studies 3,651 to 3,660 of 3,999, newest first. Back to the serotonin overview

Research

Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies.

The pharmacogenomics journal 2006 M A Davies, Vincent Setola, R T Strachan et al.

The 5-HT(2A)-serotonin receptor is a major molecular target for most atypical antipsychotic drugs as well as most hallucinogens, which can exacerbate psychotic symptoms. In this study, we examined whether random sequence variations in the gene (single nucleotide polymorphisms, SNPs) encoding the 5-HT(2A)-serotonin receptor could explain inter-individual variability in atypical antipsychotic and...

Increased responsiveness to MDMA in adult rats treated neonatally with MDMA.

Neurotoxicology and Teratology 2006 Brian J. Piper, Jerrold S. Meyer

MDMA [(+/-)3,4-methylenedioxymethamphetamine, also known as ecstasy] is a popular recreational drug among women of reproductive age. The objective of this study was to investigate the long-term neurobehavioral consequences of early developmental MDMA exposure. On postnatal days (PD) 1-4, Sprague-Dawley rats received two 10 mg/kg injections of MDMA with an inter-dose interval of 4 h. Male...

Analysis of transcriptional responses in the mouse dorsal striatum following acute 3,4-methylenedioxymethamphetamine (ecstasy): identification of extracellular signal-regulated kinase-controlled genes.

Neuroscience 2006 Julie Salzmann, C Canestrelli, Florence Noble et al.

3,4-Methylenedioxymethamphetamine (ecstasy), a widely used recreational drug with psychoactive properties, induces both serotonin and dopamine release in the brain. However, little is known about its intracellular effects. We previously showed that 3,4-methylenedioxymethamphetamine rewarding effects in mice were dependent upon extracellular signal-regulated kinase activation and that dorsal...

Evidence that the Transcendental Meditation program prevents or decreases diseases of the nervous system and is specifically beneficial for epilepsy.

Medical Hypotheses 2006 David W. Orme-Johnson

Although meditation has been practiced worldwide for centuries, there are no reports that it causes epilepsy or increases the predisposition to it. Medical care utilization statistics and clinical studies indicate that individuals who regularly practice the Transcendental Meditation technique have fewer problems of the nervous system and specifically show decreased symptoms of epilepsy. The...

Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.

Pharmacology, Biochemistry, and Behavior 2006 William E Fantegrossi, A W Harrington, C L Kiessel et al. 144 citations

Few studies have examined the effects of 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) in vivo. In these studies, 5-MeO-DIPT was tested in a drug-elicited head twitch assay in mice where it was compared to the structurally similar hallucinogen N,N-dimethyltryptamine (N,N-DMT) and challenged with the selective serotonin (5-HT)2A antagonist M100907, and in a lysergic acid diethylamide (LSD)...

Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

Proceedings of the National Academy of Sciences December 13, 2005 Gabriella Gobbi, Francis Rodriguez Bambico, Regina A. Mangieri et al. 675 citations

Although anecdotal reports suggest that cannabis may be used to alleviate symptoms of depression, the psychotropic effects and abuse liability of this drug prevent its therapeutic application. The active constituent of cannabis, delta9-tetrahydrocannabinol, acts by binding to brain CB1 cannabinoid receptors, but an alternative approach might be to develop agents that amplify the actions of...

DOI: 10.1073/pnas.0509591102 (opens in new tab) Anandamide Endocannabinoid system Pharmacology Cannabinoid receptor +5

Dextromethorphan psychosis, dependence and physical withdrawal.

Addiction Biology December 1, 2005 Shannon C Miller

As part of a synthesis of evidence regarding the abuse and addiction liability of dextromethorphan (DM), an over-the-counter cough medicine available in over 140 preparations, an uncommonly published case of dextromethorphan dependence (addiction) is described, with specific, rarely published complications. The individual was interviewed and several medical databases were also reviewed...

Zoonotic potential of emerging animal diseases

BMJ November 24, 2005 Samson S. Y. Wong, Kwok‐Yung Yuen 2 citations

Abstract 5-Methoxy-N,N-dimethyltryptamine (acronymized as 5-MeO-DMT) is sui generis among the numerous naturally-occurring psychoactive substances due to its unparalleled ego-dissolving effects which can culminate in a state of nondual consciousness (which is phenomenologically similar to transformative peak experiences described in various ancient contemplative traditions, e.g., Advaita...

Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers

Pharmacopsychiatry November 1, 2005 Euphrosyne Gouzoulis‐mayfrank, Karsten Heekeren, Anna Neukirch et al. 198 citations

INTRODUCTION: Pharmacological challenges with hallucinogens are used as models for psychosis in experimental research. The state induced by glutamate antagonists such as phencyclidine (PCP) is often considered as a more appropriate model of psychosis than the state induced by serotonergic hallucinogens such as lysergic acid diethylamide (LSD), psilocybin and N,N-dimethyltryptamine (DMT)....

Acute and chronic effects of MDMA on molecular mechanisms implicated in memory formation in rat hippocampus: surface expression of CaMKII and NMDA receptor subunits.

Pharmacology, Biochemistry, and Behavior September 9, 2005 S. Moyano, J. Del Río, D. Frechilla 29 citations

Acute 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") treatment induces learning deficits in different animal models. In a passive avoidance learning task in rats, previous studies suggested a role for Ca2+/calmodulin-dependent protein kinase II (CaMKII) and N-methyl-D-aspartate (NMDA) receptors in the acute learning impairment. As cognitive deficits by "ecstasy" in humans have been only...

DOI: 10.1016/j.pbb.2005.07.020 (opens in new tab) Hippocampus Animals Rats, wistar N-methyl-3,4-methylenedioxyamphetamine +6